PTGS2 and glioblastoma: In this study, inhibition of COX-2 by celecoxib [51] activated p53 in human glioblastoma U87MG cells, as demonstrated by translocation of p53 from cytoplasm to nucleus accompanied with accumulation of total p53 expression.